Cargando…
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
Taxol is a mitotoxin widely used to treat human cancers, including of the breast and ovary. However, taxol resistance (txr) limits treatment efficacy in human patients. To study chemoresistance in ovarian cancer, we established txr ovarian carcinoma cells derived from the SKOV3 cell lineage. The cel...
Autores principales: | Sun, Nian-Kang, Huang, Shang-Lang, Chang, Pu-Yuan, Lu, Hsing-Pang, Chao, Chuck C.-K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322968/ https://www.ncbi.nlm.nih.gov/pubmed/25460502 |
Ejemplares similares
-
Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor
por: Sun, Nian-Kang, et al.
Publicado: (2015) -
Silencing of Taxol-Sensitizer Genes in Cancer Cells: Lack of Sensitization Effects
por: Huang, Shang-Lang, et al.
Publicado: (2015) -
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
por: Hou, Shunyu, et al.
Publicado: (2018) -
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor
por: Kohli, Abhidha, et al.
Publicado: (2022) -
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
por: Maeda, Keisuke, et al.
Publicado: (2021)